WHO ICTRP trial
A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the…
EUCTR2006-006204-11-PL · EU Clinical Trials Register
Key facts
| Trial ID | EUCTR2006-006204-11-PL |
|---|---|
| Public title | A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of Manufacturing Scale 13-valent Pneumococcal Conjugate Vaccine - Manufacturing scale study |
| Scientific title | A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of Manufacturing Scale 13-valent Pneumococcal Conjugate Vaccine - Manufacturing scale study |
| Primary sponsor | Wyeth Research Division of Wyeth Pharmaceuticals Inc. |
| Registry | EU Clinical Trials Register |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Poland |
| Conditions | Healthy infants |
| Interventions | Product Name: 13vPnC pilot scale Product Code: 6096A1 Pharmaceutical Form: Suspension for injection INN or Proposed INN: Pneumococcal polysaccharide serotype 1 Concentration unit: µg/ml microgram(s)/millilitre Concentration type: equal… |
| Registration date | Dec 4, 2007 |
| Secondary IDs | 6096A1-3000;N/A |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: